News

October 20, 2014 — Boston Scientific Corp. has initiated the PLATINUM Diversity trial to evaluate the clinical performance of the Promus Premier Everolimus-Eluting Platinum...

October 20, 2014 — Sony Electronics’ Medical Systems Division is highlighting four new medical printers at RSNA 2014: models UP-D898MD, UP-X898MD, UP-991AD and UP-...

Boston Scientific CE Mark MRI Compatible Pacemaker

Boston Scientific Corp. has received CE mark approval for the Accolade pacemaker family. 

Samsung Tablet-based Ultrasound Clinical Trial Emergency Services

Samsung Electronics America Inc. announced the preliminary results of a groundbreaking trial into the use of tablet-based ultrasound in emergency services vehicles.

Heart disease and stroke are the leading causes of death and disability among people with Type 2 diabetes. At least 65 percent of people with diabetes die from some form of heart disease or stroke...

Akers Biosciences Inc. has signed a feasibility study deal with Konica Minolta Inc. to develop a rapid test for the early detection of myocardial infarction. Heart attacks are the leading cause of...

The electrophysiology service of the Massachusetts General Hospital Institute for Heart, Vascular and Stroke Care announces participation in a new Transatlantic Network of Excellence as part of a...

Materialise 3-D Printed HeartPrint Services

Materialise NV has listed its 3-D-printed cardiovascular HeartPrint models as a medical device in U.S. and EU markets.

Medtronic FDA Approval CapSureFix Novus MRI SureScan 5076 Lead

Medtronic announced the U.S. Food and Drug Administration (FDA) approval of its CapSureFix Novus MRI SureScan 5076 Lead for use with magnetic resonance imaging (MRI). 

Sunshine Heart Inc. today announced the results of its feasibility study entitled “Ambulatory Extra-Aortic Counterpulsation in Patients with Moderate to Severe Chronic Heart Failure,”...

A team of surgeons at New York-Presbyterian/Morgan Stanley Children’s Hospital saved the life of a one-week-old baby with the aid of a 3-D printed model of the child’s heart. The 3-D model was...

Neovasc Inc. has received conditional Investigational Device Exemption (IDE) approval from the U.S. FDA to initiate the U.S. arm of its Tiara-I Early Feasibility Trial for the Company's Tiara...

Imricor Medical Systems Inc. announced that it has entered into a license agreement with Sorin Group to develop magnetic resonance imaging (MRI) compatible leads for use with...

Stenting Safe Effective Long-term Stroke Prevention

Using stents to keep neck arteries open is just as effective as invasive neck surgery for long-term prevention of fatal and disabling strokes, reports an international trial led by UCL (University...

Imricor Medical Systems, Inc. announced the first three cardiac ablation procedures were completed in the first clinical study that is evaluating the feasibility of their magnetic resonance (MR)-...

October 15, 2014 — AtriCure, Inc. today announced enrollment in the ABLATE Post Approval Study (PAS) is complete.

October 15, 2014 — Novartis Pharmaceuticals Canada Inc. revealed, in the largest heart failure study to date, that its investigational heart failure medicine, LCZ696, was superior to the ACE-...

October 15, 2014 — Imaging can be a cost-effective way to identify people at risk for stroke who might benefit from aggressive intervention, according to a new modeling study published online in...

Impact of Mental Stress on Heart Varies Between Men, Women ACC Study

Men and women have different cardiovascular and psychological reactions to mental stress, according to a study of men and women who were already being treated for heart disease.

The Geneva Healthcare Suite has been proven effective by clinicians at the Douglas & Nancy Barnhart Cancer Center at Sharp Chula Vista Medical Center in managing risk for patients with cardiac...